Ozempic weight loss: Jabs could slow ageing, researchers say

Ozempic weight loss: Jabs Could Slow Ageing, Researchers Say A new study has found that the weight loss drug Ozempic could potentially slow down the aging process. Researchers have discovered that the drug's ability to promote weight loss may also have a positive impact on a range of other health issues, including heart failure. Ozempic, also known as semaglutide, is currently approved for use in treating type 2 diabetes. However, recent studies have shown that it can also be effective in aiding weight loss. The drug works by mimicking the effects of a hormone called GLP-1, which is responsible for regulating blood sugar levels and appetite. In a study published in the journal Nature Communications, researchers from the University of Southampton in the UK found that Ozempic not only helps with weight loss but also improves cardiac function. The researchers conducted experiments on mice and discovered that the drug increased the energy-producing capacity of the heart and improved its overall function. These findings have significant implications for the treatment of heart failure, a condition that affects millions of people worldwide. Heart failure occurs when the heart is unable to pump enough blood to meet the body's needs, leading to symptoms such as fatigue, shortness of breath, and fluid retention. It is a chronic and progressive condition that currently has limited treatment options. The researchers believe that by improving cardiac function, Ozempic could potentially be used to treat heart failure and improve the overall quality of life for patients. The